دورية أكاديمية
1032P Safety data from stratum D of the phase I INSIGHT platform trial evaluating feasibility of IMP321 (LAG-3Ig protein, eftilagimod alpha) combined with avelumab in advanced stage solid tumour entities
| العنوان: | 1032P Safety data from stratum D of the phase I INSIGHT platform trial evaluating feasibility of IMP321 (LAG-3Ig protein, eftilagimod alpha) combined with avelumab in advanced stage solid tumour entities |
|---|---|
| المؤلفون: | Goetze, T.O., Müller, D.W., Rafiyan, M-R., Kiselicki, D., Habibzade, T., Eickhoff, R., Jäger, E., Al-Batran, S-E. |
| المصدر: | In Annals of Oncology September 2020 31 Supplement 4:S712-S712 |
| قاعدة البيانات: | ScienceDirect |
| تدمد: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2020.08.1152 |